Evidence of anaphylaxy after alteplase infusion

Stroke

Volumn 30, Issue 5, 1999, Pages 1142-1143

  Rudolf, Jobst ^a   Grond, Martin ^a   Prince, William S ^b   Schmülling, Susanne ^a   Heiss, Wolf Dieter ^a,c  

^a UNIVERSITY OF COLOGNE   (Germany)

^b GENENTECH INC   (United States)

^c MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

Author keywords

Alteplase; Anaphylaxis; Antibodies

Indexed keywords

ALTEPLASE; DRUG ANTIBODY; EPITOPE; IMMUNOGLOBULIN E;

AGED; ANAPHYLAXIS; ANTIBODY DETECTION; ARTICLE; BLOOD CLOT LYSIS; CASE REPORT; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CROSS REACTION; CYANOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMIPARESIS; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIOIMMUNOPRECIPITATION; SINUS TACHYCARDIA; UNCONSCIOUSNESS;

EID: 0032899029     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.30.5.1142     Document Type: Article

References (4)

1. Massel D, Gill JB, Cairns JA. Anaphylactoid reaction during an infusion of recombinant tissue-type plasminogen activator for acute myocardial infarction. Can J Cardiol. 1991;7:298-302.
2. Okpara AU, Egbunike IG, Jackson DJ, Stewart K. Anaphylactoid reaction following infusion of tissue plasminogen activator. Hosp Pharm. 1994;29: 588-590.
3. Purvis JA, Booth NA, Wilson CM, Adgey AAJ, McCluskey DR. Anaphylactoid reaction after injection of alteplase. Lancet. 1993;341:966-967.
4. Criqui MH, Lee ER, Hamburger RN, Klauber MR, Coughlin SS. IgE and cardiovascular disease. Am J Med. 1987;82:964-968.